Becker Muscular Dystrophy - 32 Studies Found

Withdrawn : Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cell Therapy for Patients With Duchenne Muscular Dystrophy
: Duchenne Muscular Dystrophy
: 2012-05-21
: Biological: human umbilical cord mesenchymal stem cells rehabilitation therapy plus human umbilical cord
Recruiting : An Extension Study to Assess Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD)
: Duchenne Muscular Dystrophy
: 2016-04-28
:
  • Drug: Vamorolone 0.25 mg/day/day

Recruiting : A Study to Assess Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD)
: Duchenne Muscular Dystrophy
: 2016-04-28
:
  • Drug: Vamorolone 0.25 mg/kg/day

Enrolling by invitation : Long-term Extension Study to Assess Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD)
: Duchenne Muscular Dystrophy
: 2017-01-30
:
  • Drug: Vamorolone 0.25 mg/day/day

Active, not recruiting : Dose-Titration and Open-label Extension Study of SRP-4045 in Advanced Stage Duchenne Muscular Dystrophy (DMD) Patients
: Duchenne Muscular Dystrophy
: 2015-08-10
:
  • Drug: SRP-4045
  • Drug: Placebo
Completed : Prospective Becker-Heart-Study
:
  • Dilated Cardiomyopathy
  • Lef Ventricular Dysfunction
  • Heart F
    : 2013-12-19
    : Procedure: ECG, echocardiography, cardiac MRI, sera biomarkers
Completed : Constipation and Gut Transit in DMD Patients
:
  • Constipation
  • DMD

: 2013-06-26
: Device: SmartPill ingestion The participant would ingest the SmartPill and wear the data receiver for up
Recruiting : Biomechanical and Morphological Changes in Dystrophic Muscle
: Duchenne Dystrophy Muscular
: 2015-06-10
: Other: No drug and no placebo were used in this study measures of muscular strength of legs, motor funct
Recruiting : Study to Assess the Safety, Tolerability and PK Response and Explore the PD Response Following 4 Weekly SC Injections of PB1046 in Subjects With Stable Heart Failure With Reduced Ejection Fraction (HFrEF)
: Heart Failure
: 2016-06-08
:
  • Drug: PB1046 Injection Four we
Recruiting : 1 Year Open-label Extension to CZOL446H2337 Safety and Efficacy Trial of Zoledronic Acid Twice Yearly in Osteoporotic Children Treated With Glucocorticoids
: Osteoporosis
: 2010-09-07
: Drug: zoledronic acid
<<< Previous | Next >>>